AstraZeneca Wang Lei: Continue to increase investment in research and development and medical innovation in China
阿豆学长长ov
发表于 2023-11-5 17:09:09
257
0
0
Wang Lei, Global Executive Vice President and President of International Business and China at AstraZeneca, stated that over the past five years, relying on the advantages of China's large market, CIIE has made positive contributions to accelerating the construction of a new development pattern and promoting world economic development. Through the CIIE, AstraZeneca deeply felt the signal of China's adherence to opening-up and continued support for economic globalization, as well as its responsible image as a major country.
Wang Lei stated that AstraZeneca, as an old friend of CIIE, has participated in six consecutive exhibitions this year. Relying on the strong influence and spillover effects of the CIIE platform, AstraZeneca will announce the latest progress in investment in China at this CIIE, continue to increase investment in China, including research and development, medical innovation, and promote production and supply layout. AstraZeneca will also work with cross-border partners to continuously assist Chinese enterprises and innovative achievements in accelerating their "going global" journey, creating a "global new" with "China's new" approach, promoting the sustainable development of healthcare and contributing to the cause of human health.
Wang Lei stated that history has proven that the Chinese economy is a very stable development ship, and China is one of the largest markets in the world. AstraZeneca will use a more determined belief to play a role as a link and bridge, deepening its long-term commitment to "rooted in China, serving China, and benefiting the world".
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Gilead Science's second HIV pre exposure prophylactic drug has been approved in China, and the awareness rate of PrEP in China is still relatively low
- The big news of "weight loss miracle drug"! Oral Smegglutide Approved for Market in China
- Industry shock! Alibaba Cloud suddenly announced the largest price reduction in history!
- Continuously focusing on content and increasing AI investment in iQiyi's current year
- Novo Nordisk's new weight loss oral medication is applying for clinical efficacy or surpassing smeglutide in China
- How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
- "Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
- Yizi International expands its business in China and adds equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 前天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 昨天 17:41
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 昨天 16:27
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 昨天 14:41
- 支持
- 反对
- 回复
- 收藏